GlassScriptPhysician profile
Chase Jonathan Whelan
NPI 1023590502
$1,532.10
in general payments reported to CMS, 2019-2025
12 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $148 · 2022: $505 · 2023: $413 · 2024: $249 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $708.93 | 2021-2025 | Solitaire X, Pipeline, Axium Primetm |
| Boston Scientific Corporation | $278.29 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Aesculap, INC. | $145.74 | 2021-2023 | Aesculap, M.Blue |
| Stryker Corporation | $123.96 | 2021-2024 | Trevo, Target |
| Surgalign Spine Technologies, INC. | $65.84 | 2022 | |
| Orthofix Medical, INC. | $65.46 | 2021-2023 | Physio-Stim |
| Si-Bone, INC. | $40.12 | 2024-2025 | |
| Baxter Healthcare | $35.55 | 2024 | Floseal |
| Olympus America INC. | $26.72 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.40 | 2022 | |
| Paratek Pharmaceuticals, INC. | $13.96 | 2023 | Nuzyra |
| Gt Medical Technologies, INC | $13.13 | 2024 | Gammatile |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Whelan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.